Plasmodium vivax : comparison of immunogenicity among proteins expressed in the cell-free systems of Escherichia coli and wheat germ by suspension array assays

Abstract Background In vitro cell-free systems for protein expression with extracts from prokaryotic ( Escherichia coli ) or eukaryotic (wheat germ) cells coupled to solid matrices have offered a valid approach for antigen discovery in malaria research. However, no comparative analysis of both syste...

Full description

Bibliographic Details
Published in:Malaria Journal
Main Authors: Tsuboi Takafumi, Lacerda Marcus VG, Sanz Sergi, Takeo Satoru, Fernandez-Becerra Carmen, Rui Edmilson, del Portillo Hernando A
Format: Article in Journal/Newspaper
Language:English
Published: BMC 2011
Subjects:
Online Access:https://doi.org/10.1186/1475-2875-10-192
https://doaj.org/article/fd5221e6927f42baa4d44f3d5b2981bd
Description
Summary:Abstract Background In vitro cell-free systems for protein expression with extracts from prokaryotic ( Escherichia coli ) or eukaryotic (wheat germ) cells coupled to solid matrices have offered a valid approach for antigen discovery in malaria research. However, no comparative analysis of both systems is presently available nor the usage of suspension array technologies, which offer nearly solution phase kinetics. Methods Five Plasmodium vivax antigens representing leading vaccine candidates were expressed in the E. coli and wheat germ cell-free systems at a 50 μl scale. Products were affinity purified in a single-step and coupled to luminex beads to measure antibody reactivity of human immune sera. Results Both systems readily produced detectable proteins; proteins produced in wheat germ, however, were mostly soluble and intact as opposed to proteins produced in E. coli , which remained mostly insoluble and highly degraded. Noticeably, wheat germ proteins were recognized in significantly higher numbers by sera of P. vivax patients than identical proteins produced in E. coli . Conclusions The wheat germ cell-free system offers the possibility of expressing soluble P. vivax proteins in a small-scale for antigen discovery and immuno-epidemiological studies using suspension array technology.